Honored with the 2026 Women Entrepreneur Awards for Her Outstanding Leadership in Biotechnology Innovation and Cross-Generational Industry Impact
On November 9, 2026, at the Hua Nan Bank International Convention Center, Sarina Lin, Vice Chairwoman and General Manager of Honeybear Biosciences Inc., was personally presented with the “2026 Women Entrepreneur Awards” by Minister of Economic Affairs Kung Ming-Hsin at the award ceremony, hosted by Taiwan’s Ministry of Economic Affairs (MOEA). This prestigious recognition celebrates Sarina Lin’s outstanding achievements in business management, strategic leadership, and her contributions to innovation, entrepreneurship, and social development. It also highlights the significant role of women leaders in driving industrial innovation and transformation in Taiwan.
With a professional background as a licensed pharmacist, Sarina brings more than 25 years of international pharmaceutical industry management experience, having previously served at Novartis. Her extensive experiences span corporate strategy, business operations, brand marketing, and multinational team leadership. Drawing on her profound industry expertise and global perspective, she not only demonstrates strong capabilities in anticipating market trends but also places great emphasis on talent development, organizational growth, and long-term corporate competitiveness. Her leadership embodies a distinctive blend of professional excellence and human-centered values.
In recent years, Sarina has leveraged her extensive pharmaceutical industry experience to advance innovation in the biotechnology sector. Under her leadership, Honeybear Biosciences has been actively developing next-generation Antibody-Drug Conjugates (ADCs) and Antibody-Radionuclide Conjugates (ARCs), with its core proprietary CoNectar® site-specific conjugation technology platform. By integrating international research resources and strategic partnerships, the company is accelerating the development and global advancement of innovative cancer therapeutics, with the vision of strengthening Taiwan’s technological capabilities and global competitiveness in the biotechnology industry.
Beyond her demanding corporate responsibilities and commitment to innovative R&D, Sarina also dedicates her personal time to women's health advocacy, charitable initiatives, and talent development. Through her experience and influence, she hopes to inspire more women to break through career boundaries, realize their professional potential, and create lasting positive value for both industry and society.
This award not only recognizes the leadership achievements of Sarina Lin, Vice Chairman and General Manager of Honeybear Biosciences, but also grants the company's continued commitment to innovative R&D, international collaboration, and sustainable business development. Looking ahead, Honeybear Biosciences will continue to pursue its vision of "Rooted in Taiwan, Reaching the World," accelerating the development of its ADC and ARC pipelines and building an innovative drug development platform with strong global potential. Through these efforts, the company aims to create new opportunities and contribute to the continued advancement of Taiwan's biotechnology industry.
On November 9, 2026, at the Hua Nan Bank International Convention Center, Sarina Lin, Vice Chairwoman and General Manager of Honeybear Biosciences Inc., was personally presented with the “2026 Women Entrepreneur Awards” by Minister of Economic Affairs Kung Ming-Hsin at the award ceremony, hosted by Taiwan’s Ministry of Economic Affairs (MOEA). This prestigious recognition celebrates Sarina Lin’s outstanding achievements in business management, strategic leadership, and her contributions to innovation, entrepreneurship, and social development. It also highlights the significant role of women leaders in driving industrial innovation and transformation in Taiwan.
With a professional background as a licensed pharmacist, Sarina brings more than 25 years of international pharmaceutical industry management experience, having previously served at Novartis. Her extensive experiences span corporate strategy, business operations, brand marketing, and multinational team leadership. Drawing on her profound industry expertise and global perspective, she not only demonstrates strong capabilities in anticipating market trends but also places great emphasis on talent development, organizational growth, and long-term corporate competitiveness. Her leadership embodies a distinctive blend of professional excellence and human-centered values.
In recent years, Sarina has leveraged her extensive pharmaceutical industry experience to advance innovation in the biotechnology sector. Under her leadership, Honeybear Biosciences has been actively developing next-generation Antibody-Drug Conjugates (ADCs) and Antibody-Radionuclide Conjugates (ARCs), with its core proprietary CoNectar® site-specific conjugation technology platform. By integrating international research resources and strategic partnerships, the company is accelerating the development and global advancement of innovative cancer therapeutics, with the vision of strengthening Taiwan’s technological capabilities and global competitiveness in the biotechnology industry.
Beyond her demanding corporate responsibilities and commitment to innovative R&D, Sarina also dedicates her personal time to women's health advocacy, charitable initiatives, and talent development. Through her experience and influence, she hopes to inspire more women to break through career boundaries, realize their professional potential, and create lasting positive value for both industry and society.
This award not only recognizes the leadership achievements of Sarina Lin, Vice Chairman and General Manager of Honeybear Biosciences, but also grants the company's continued commitment to innovative R&D, international collaboration, and sustainable business development. Looking ahead, Honeybear Biosciences will continue to pursue its vision of "Rooted in Taiwan, Reaching the World," accelerating the development of its ADC and ARC pipelines and building an innovative drug development platform with strong global potential. Through these efforts, the company aims to create new opportunities and contribute to the continued advancement of Taiwan's biotechnology industry.
Sarina Lin, Vice Chairwoman and General Manager of Honeybear Biosciences Inc., was personally presented with the “2026 Women Entrepreneur Awards” by Minister of Economic Affairs Kung Ming-Hsin at the award ceremony.
